Skip to Content
myAACR
Donate Today

Progress Against Cancer

Home » Patients, Caregivers, and Advocates » Progress Against Cancer » Research

Recent Progress: FDA Approvals

Chemotherapy for a Rare Pediatric Cancer 

Chemotherapy for a Rare Pediatric Cancer 

The FDA approved the chemotherapeutic azacitidine for patients with juvenile myelomonocytic leukemia  The U.S. Food and Drug Administration (FDA) has approved azacitidine (Vidaza) for pediatric patients with newly diagnosed juvenile myelomonocytic leukemia (JMML).  Azacitidine...